GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Henan Taloph Pharmaceutical Stock Co Ltd (SHSE:600222) » Definitions » Debt-to-Equity

Henan Taloph Pharmaceutical Stock Co (SHSE:600222) Debt-to-Equity : 0.56 (As of Jun. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Henan Taloph Pharmaceutical Stock Co Debt-to-Equity?

Henan Taloph Pharmaceutical Stock Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was ¥845 Mil. Henan Taloph Pharmaceutical Stock Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was ¥18 Mil. Henan Taloph Pharmaceutical Stock Co's Total Stockholders Equity for the quarter that ended in Jun. 2024 was ¥1,552 Mil. Henan Taloph Pharmaceutical Stock Co's debt to equity for the quarter that ended in Jun. 2024 was 0.56.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Henan Taloph Pharmaceutical Stock Co's Debt-to-Equity or its related term are showing as below:

SHSE:600222' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.33   Med: 0.69   Max: 0.92
Current: 0.56

During the past 13 years, the highest Debt-to-Equity Ratio of Henan Taloph Pharmaceutical Stock Co was 0.92. The lowest was 0.33. And the median was 0.69.

SHSE:600222's Debt-to-Equity is ranked worse than
68.62% of 838 companies
in the Drug Manufacturers industry
Industry Median: 0.3 vs SHSE:600222: 0.56

Henan Taloph Pharmaceutical Stock Co Debt-to-Equity Historical Data

The historical data trend for Henan Taloph Pharmaceutical Stock Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Henan Taloph Pharmaceutical Stock Co Debt-to-Equity Chart

Henan Taloph Pharmaceutical Stock Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.83 0.92 0.71 0.42 0.45

Henan Taloph Pharmaceutical Stock Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.51 0.45 0.45 0.53 0.56

Competitive Comparison of Henan Taloph Pharmaceutical Stock Co's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Henan Taloph Pharmaceutical Stock Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Henan Taloph Pharmaceutical Stock Co's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Henan Taloph Pharmaceutical Stock Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Henan Taloph Pharmaceutical Stock Co's Debt-to-Equity falls into.



Henan Taloph Pharmaceutical Stock Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Henan Taloph Pharmaceutical Stock Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Henan Taloph Pharmaceutical Stock Co's Debt to Equity Ratio for the quarter that ended in Jun. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Henan Taloph Pharmaceutical Stock Co  (SHSE:600222) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Henan Taloph Pharmaceutical Stock Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Henan Taloph Pharmaceutical Stock Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Henan Taloph Pharmaceutical Stock Co Business Description

Traded in Other Exchanges
N/A
Address
No. 8, Jinsuo Road, High-tech Industrial Development Zone, Henan Province, Zhengzhou, CHN, 450001
Henan Taloph Pharmaceutical Stock Co Ltd is a Chinese company engaged in the manufacture of Western and Chinese medicine products, including oral liquids, tablets, capsules, and bulk drugs. Geographically, the business activities are functioned through China region.
Executives
Zhao Qing Xin Director

Henan Taloph Pharmaceutical Stock Co Headlines

No Headlines